Valuation: Enovis Corporation

Market Cap 1.22B 1.09B 1.01B 911M 1.7B 116B 1.73B 12.1B 4.79B 60.49B 4.56B 4.47B 192B P/E 2026 *
104x
P/E 2027 * 32.2x
Enterprise Value 2.52B 2.26B 2.09B 1.89B 3.54B 240B 3.59B 25.11B 9.93B 125B 9.47B 9.26B 397B EV / Sales 2026 *
1.08x
EV / Sales 2027 * 1x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day-0.43%
1 week+5.84%
Current month+15.11%
1 month+15.80%
3 months-25.56%
6 months-14.30%
Current year-21.06%
1 week 19.89
Extreme 19.89
21.73
1 month 16.7
Extreme 16.7
21.73
Current year 16.7
Extreme 16.7
31.66
1 year 16.7
Extreme 16.7
34.28
3 years 16.7
Extreme 16.7
65.03
5 years 16.7
Extreme 16.7
164.01
10 years 16.7
Extreme 16.7
164.01
Manager TitleAgeSince
Chief Executive Officer 61 2025-05-11
Director of Finance/CFO 47 2022-12-31
Chief Tech/Sci/R&D Officer - 2025-12-31
Director TitleAgeSince
Director/Board Member 55 2008-05-12
Director/Board Member 67 2010-09-20
Chairman 64 2025-05-20
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

958 0.0017%
9/4/26 Buy

Chief Administrative Officer

2,660 0.0047%
9/4/26 Buy

Chief Executive Officer

13,035 0.0228%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+5.84%-36.00%-51.84% 1.22B
+0.31%+0.10%-18.10%+10.83% 179B
-1.10%+1.94%-20.85%+17.46% 118B
-1.24%+1.60%+0.13%+33.93% 117B
-3.42%+15.09%-44.71%+5.61% 93.26B
-0.09%-2.44%-1.29%+75.88% 63.16B
+0.04%+1.79%+13.52%+75.53% 55.68B
-2.00%+2.34%+4.37%-23.20% 54.18B
+1.52%+2.39%-12.09%+43.20% 44.15B
+0.03%+6.23%-4.20%-7.53% 33.95B
Average -0.63%+3.72%-11.92%+17.99% 75.96B
Weighted average by Cap. -0.77%+3.06%-12.73%+23.45%

Financials

2026 *2027 *
Net sales 2.34B 2.09B 1.94B 1.75B 3.28B 223B 3.33B 23.29B 9.21B 116B 8.78B 8.59B 369B 2.45B 2.19B 2.03B 1.84B 3.44B 233B 3.5B 24.43B 9.66B 122B 9.21B 9.01B 387B
Net income 11.38M 10.17M 9.41M 8.52M 15.95M 1.08B 16.21M 113M 44.79M 566M 42.69M 41.78M 1.79B 29.72M 26.58M 24.59M 22.27M 41.67M 2.83B 42.36M 296M 117M 1.48B 112M 109M 4.68B
Net Debt 1.31B 1.17B 1.08B 978M 1.83B 124B 1.86B 13B 5.14B 65B 4.9B 4.8B 206B 1.25B 1.11B 1.03B 933M 1.75B 118B 1.77B 12.4B 4.9B 61.96B 4.67B 4.57B 196B
Projected Income Statement - Annual - Enovis Corporation
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
26-10-26 $21.02 -0.28% 245,736
26-10-23 $21.08 -2.36% 954,300
26-10-22 $21.59 +3.75% 1,295,357
26-10-21 $20.81 +0.58% 1,204,040
26-10-20 $20.69 +4.13% 1,185,246
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Enovis Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
21.08USD
Average target price
36.08USD
Spread / Average Target
+71.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Enovis Corporation
  1. Stock Market
  2. Stocks
  3. ENOV Stock